Neonode (NASDAQ:NEON) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Neonode is a company that designs, develops and sells patented technologies and products focused on unique user experiences. With offices in Stockholm, Sweden and San Ramon, California, Neonode Inc. is a company with licenses and products sold worldwide through both direct web sales and local distribution partners. “
NewJersey Resources (NYSE:NJR) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $44.00 price target on the stock. According to Zacks, “New Jersey Resources Corporation is an energy services holding company that, through its subsidiaries, provides safe and reliable natural gas and clean energy services, including transportation, distribution, asset management and home services. NJR is composed of five primary businesses: New Jersey Natural Gas, NJR’s principal subsidiary, operates and maintains the natural gas transportation and distribution infrastructure to serve the customers. NJR Clean Energy Ventures invests in, owns and operates solar and onshore wind projects. NJR Energy Services manages a diversified portfolio of natural gas transportation and storage assets and provides physical natural gas services and customized energy solutions. NJR Midstream serves customers from local distributors and producers to electric generators and wholesale marketers. NJR Home Services provides service contracts as well as heating, central air conditioning, water heaters, standby generators, solar and other indoor and outdoor comfort products. “
Northwest Pipe (NASDAQ:NWPX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Northwest Pipe Company manufactures welded steel pipe in two business segments. In its Water Transmission business, they are a supplier of large diameter, high-pressure steel pipe used primarily for water transmission. In its Tubular Products business, they manufacture smaller diameter, electric resistance welded steel pipe for use in a wide range of construction, agricultural, energy and industrial applications. “
NxStage Medical (NASDAQ:NXTM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. “
Oaktree Capital Group (NYSE:OAK) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Oaktree Capital Group, LLC is an investment management firm focused on alternative markets. It specializes in credit and contrarian, value-oriented investing. The Company manages funds in investment strategies that fall into the six asset classes, which include: distressed debt, corporate debt, control investing, convertible securities, real estate and listed equities. Oaktree Capital Group, LLC is based in Chicago, Illinois. “
Obalon Therapeutics (NASDAQ:OBLN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Obalon Therapeutics, Inc. is a medical device company. It focused on developing and commercializing medical devices to treat obese and overweight. The company’s product consists of Obalon balloon system, the first swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients. Obalon Therapeutics, Inc. is based in San Diego, California. “
Osisko Gold Royalties (NYSE:OR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Osisko Gold Ltd is a mining company which is engaged in exploration and mining for gold and other precious metals. Osisko Gold Ltd is headquartered in Montreal, Canada. “
Orion Group (NYSE:ORN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Orion Group Holdings, Inc. is a construction company which provides services on and off the water primarily in the continental United States, Alaska, Canada and the Caribbean Basin. The company’s operating segment consists of heavy civil marine construction segment and commercial concrete segment. Heavy civil marine construction segment services includes marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design and specialty services. Commercial concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas. Orion Group Holdings, Inc., formerly known as Orion Marine Group Inc., is headquartered in Houston, Texas. “
OraSure Technologies (NASDAQ:OSUR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. “
Venture Life Group (LON:VLG) had its buy rating reiterated by analysts at Northland Securities. They currently have a GBX 94 ($1.30) target price on the stock.
Receive News & Ratings for Neonode Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonode Inc and related companies with MarketBeat.com's FREE daily email newsletter.